⌘K

Login Start Free

Home/Filings/4/0001062993-25-001620

4//SEC Filing

Doyle John Brendan 4

Accession 0001062993-25-001620

CIK 0001455365other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:12 PM ET

Size

4.8 KB

Accession

0001062993-25-001620

Insider Transaction Report

Form 4

Period: 2025-02-04

COGNITION THERAPEUTICS INCCGTX

Doyle John Brendan

Chief Financial Officer

Transactions

Award
Common Stock
2025-02-04+295,000→ 416,125 total

Footnotes (1)

[F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

COGNITION THERAPEUTICS INC

CIK 0001455365

Entity typeother

Related Parties

1

filerCIK 0001840738

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 4:12 PM ET
Size: 4.8 KB

View on SEC.gov